ReviewDrug design, development and therapy2022

Progress on SARS-CoV-2 3CLpro Inhibitors: Inspiration from SARS-CoV 3CLpro Peptidomimetics and Small-Molecule Anti-Inflammatory Compounds.

Jiajie Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.